Boehringer Ingelheim, which has been active in the health sector for more than 130 years, offers its employees security and stability. Continuous but cautious growth has resulted in top-class solutions for improving human and animal health. The company provides plenty of opportunities and encourages all employees to make decisions and assume responsibility. We foster this winning spirit empathically to enable us to remain agile and to grow together.
One of the most up-to-date production facilities in the world is currently being completed at the Regional Center Vienna (RCV) in Vienna’s 12th district. We have invested over 700 million euros in it and created more than five hundred jobs. You would be joining over two thousand colleagues from more than thirty countries.
Since the early 1960s, Boehringer Ingelheim has been conducting research into new drugs. We have been focusing since 2000 on two particularly areas, namely cancer-cell-directed therapy and oncological immune therapy, seeking breakthroughs in both areas for cancer patients.
Click here to find out more.
Boehringer Ingelheim, which has been active in the health sector for more than 130 years, offers its employees security and stability. Through responsible growth we have created an exemplary, well‑rounded and world-class environment for our employees.
Click here to find out more.
Being at the cutting edge for 130 years calls today for the focused exploitation of the power and logic of IT. We are driven by our creativity and love of innovation, and the dynamic everyday activity and responsibility create an ideal environment for technological progress as an essential component of our overall success.